CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors (Q47447585)

16 January 2018

http://europepmc.org/abstract/MED/29097596

title

CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors (English)

1 reference

16 January 2018

http://europepmc.org/abstract/MED/29097596

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

Julia Castello

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

Heike Rebholz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

author name string

Lauren Malave

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

M Angela Cenci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

Eitan Friedman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

Marc Flajolet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

language of work or name

English

0 references

publication date

2 November 2017

1 reference

16 January 2018

http://europepmc.org/abstract/MED/29097596

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

issue

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

page(s)

11930-11946

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

describes a project that uses

15 May 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6596830/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys

1 reference

12 December 2020

Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors

1 reference

12 December 2020

Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment

1 reference

12 December 2020

Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease

1 reference

12 December 2020

Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice

1 reference

12 December 2020

Preventing levodopa-induced dyskinesias

1 reference

12 December 2020

1 reference

12 December 2020

Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum

1 reference

12 December 2020

Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats

1 reference

12 December 2020

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

1 reference

12 December 2020

Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum

1 reference

12 December 2020

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

1 reference

12 December 2020

Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats

1 reference

12 December 2020

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

1 reference

12 December 2020

D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.

1 reference

12 December 2020

Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality

1 reference

12 December 2020

Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer

1 reference

12 December 2020

Parkinson's disease: mechanisms and models

1 reference

12 December 2020

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

1 reference

12 December 2020

Casein kinase II-mediated phosphorylation regulates alpha-synuclein/synphilin-1 interaction and inclusion body formation

1 reference

12 December 2020

Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function

1 reference

12 December 2020

Caffeine as a psychomotor stimulant: mechanism of action.

1 reference

12 December 2020

Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.

1 reference

12 December 2020

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

1 reference

12 December 2020

Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

1 reference

12 December 2020

Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence

1 reference

12 December 2020

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

1 reference

12 December 2020

ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice

1 reference

12 December 2020

Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias

1 reference

12 December 2020

Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants

1 reference

12 December 2020

How common are the "common" neurologic disorders?

1 reference

12 December 2020

Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model

1 reference

12 December 2020

Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia

1 reference

12 December 2020

Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum

1 reference

12 December 2020

Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

1 reference

12 December 2020

Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs

1 reference

12 December 2020

Localization of CKII beta subunits in Lewy bodies of Parkinson's disease

1 reference

12 December 2020

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

1 reference

12 December 2020

The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development

1 reference

12 December 2020

Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene

1 reference

12 December 2020

L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice

1 reference

12 December 2020

CK2 negatively regulates Galphas signaling

1 reference

12 December 2020

Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat.

1 reference

12 December 2020

Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms.

1 reference

12 December 2020

Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease

1 reference

12 December 2020

Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors

1 reference

12 December 2020

l-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

1 reference

12 December 2020

Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease

1 reference

12 December 2020

Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia

1 reference

12 December 2020

Enhanced striatal cholinergic neuronal activity mediatesl-DOPA–induced dyskinesia in parkinsonian mice

1 reference

12 December 2020

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

1 reference

12 December 2020

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

12 December 2020

Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease

1 reference

12 December 2020

Nuclear Extracellular Signal-Regulated Kinase 1 and 2 Translocation Is Mediated by Casein Kinase 2 and Accelerated by Autophosphorylation

1 reference

12 December 2020

Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens.

1 reference

12 December 2020

Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia.

1 reference

12 December 2020

Caffeine for treatment of Parkinson disease: a randomized controlled trial

1 reference

12 December 2020

Selective knockout of the casein kinase 2 in d1 medium spiny neurons controls dopaminergic function

1 reference

12 December 2020

Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma

1 reference

12 December 2020

GENSAT BAC cre-recombinase driver lines to study the functional organization of cerebral cortical and basal ganglia circuits

1 reference

12 December 2020

Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice.

1 reference

12 December 2020

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia

1 reference

12 December 2020

Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.

1 reference

12 December 2020

Diversity and Bias through Receptor-Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization.

1 reference

12 December 2020

A partial lesion model of Parkinson's disease in mice--characterization of a 6-OHDA-induced medial forebrain bundle lesion

1 reference

12 December 2020

CK2-An Emerging Target for Neurological and Psychiatric Disorders

1 reference

12 December 2020

Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics

1 reference

12 December 2020

Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa

1 reference

12 December 2020

Striatal G-proteins: effects of unilateral 6-hydroxydopamine lesions

1 reference

12 December 2020

Coexpression of dopamine D2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum

1 reference

12 December 2020

G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase

1 reference

12 December 2020

Levels of stimulatory G protein are increased in the rat striatum after neonatal lesion of dopamine neurons

1 reference

12 December 2020

Adenosine A2A Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys

1 reference

12 December 2020

10.1523/JNEUROSCI.0443-17.2017

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6596830&resulttype=core&format=json

15 May 2020

1 reference